Browsing by Autor "Olga Marina Sanabria Cruz"

Now showing 1 - 3 of 3

Quality assurance for antimicrobial susceptibility testing of<i>Neisseria gonorrhoeae</i>in Latin American and Caribbean countries, 2013–2015
(BMJ, 2018) Pam Sawatzky; Irene Martín; Patricia Galarza; Marıa Elena Trigoso Carvallo; Pamela Araya Rodriguez; Olga Marina Sanabria Cruz; Alina Llop Hernández; Mario Fabian Martinez; Graciela Borthagaray; Daisy Payares
The participating laboratories had acceptable results, similar to other international quality assurance programmes. It is important to ensure continuation of the International Gonococcal Antimicrobial Susceptibility Quality Control Comparison Programme to ensure that participants can identify and correct any problems in antimicrobial susceptibility testing for <i>N. gonorrhoeae</i> as they arise and continue to generate reproducible and reliable data.
Resistance to Ceftriaxone and Azithromycin in Neisseria gonorrhoeae Isolates From 7 Countries of South America and the Caribbean: 2010–2011
(Lippincott Williams & Wilkins, 2017) Sidharath Dev Thakur; Pamela Araya; Graciela Borthagaray; Patricia Galarza; Alina Llop Hernández; Daisy Payares; Olga Marina Sanabria Cruz; Marıa Elena Trigoso Carvallo; Aura Helena Corredor; Jo‐Anne R. Dillon
Seven countries in Latin America and the Caribbean report on (2010 and 2011) the susceptibility of 2235 isolates of Neisseria gonorrhoeae to 6 antibiotics. Thirteen isolates had ceftriaxone minimum inhibitory concentrations (MICs) of 0.125 to ≥ 0.25 mg/L. The percentage of resistant isolates to the following antibiotics was: azithromycin, 1.0% to 1.7%; ciprofloxacin, 42.1% to 36.2%; penicillin, 31% to 35%; tetracycline, 21.8% to 22.6%.
Retrospective Analysis of Antimicrobial Susceptibility Trends (2000–2009) in Neisseria gonorrhoeae Isolates from Countries in Latin America and the Caribbean Shows Evolving Resistance to Ciprofloxacin, Azithromycin and Decreased Susceptibility to Ceftriaxone
(Lippincott Williams & Wilkins, 2012) Stefania Starnino; Patricia Galarza; Marıa Elena Trigoso Carvallo; Adele Schwartz Benzaken; A. Maldonado Ballesteros; Olga Marina Sanabria Cruz; Alina Llop Hernández; José Luis Portilla Carbajal; Graciela Borthagaray; Daisy Payares
The report of ceftriaxone-resistant isolates coupled with the emergence and spread of resistance to ciprofloxacin and azithromycin in Latin America and the Caribbean in the 2000s indicates the importance of active surveillance of N. gonorrhoeae antimicrobial susceptibility to determine antimicrobial resistance emerging trends so as to promptly inform and guide the development of effective treatment options for gonococcal infections.